Advanced

Re: Activity and Safety of ODM-201 in Patients with Progressive Metastatic Castration-resistant Prostate Cancer (ARADES): An Open-label Phase 1 Dose-escalation and Randomised Phase 2 Dose Expansion Trial

Bjartell, Anders LU (2015) In European Urology 67(2). p.348-349
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
European Urology
volume
67
issue
2
pages
348 - 349
publisher
Elsevier
external identifiers
  • wos:000347033500045
  • scopus:84920642245
  • pmid:25760250
ISSN
1873-7560
DOI
10.1016/j.eururo.2014.11.019
language
English
LU publication?
yes
id
6ee90f7b-f8e1-474d-b53d-6c0a36dd1b7d (old id 5085003)
date added to LUP
2015-03-02 07:10:40
date last changed
2017-01-01 06:25:36
@misc{6ee90f7b-f8e1-474d-b53d-6c0a36dd1b7d,
  author       = {Bjartell, Anders},
  issn         = {1873-7560},
  language     = {eng},
  number       = {2},
  pages        = {348--349},
  publisher    = {Elsevier},
  series       = {European Urology},
  title        = {Re: Activity and Safety of ODM-201 in Patients with Progressive Metastatic Castration-resistant Prostate Cancer (ARADES): An Open-label Phase 1 Dose-escalation and Randomised Phase 2 Dose Expansion Trial},
  url          = {http://dx.doi.org/10.1016/j.eururo.2014.11.019},
  volume       = {67},
  year         = {2015},
}